Subscriptions are live: We're on the subscription model now, early-access price $24.99/month, with day, week, and longer plans too. New accounts start with 5 free premium days. Prefer to donate? Donations grant premium time and are logged on your profile page.

Plans & pricing
Donate for premium time
Logo
Sign In

$CANF

Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares

XASE

$3.54+10.62%+$0.3400Prev $3.20LIVE Full chart Live alerts
No recent price bars, the chart lights up when CANF starts printing.

Why is CANF up today? It is at $3.54 (+10.62%), and our scanner flagged it 8 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CANF spikes, and full due diligence on CANF — key stats, earnings, dilution and insider activity. Free.

Free alerts

Get free $CANF alerts the moment volume spikes

Our scanner flagged $CANF 8 times in the last 30 days. Create a free account to track $CANF, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Key Stats

Price & performance
Price
$3.54
Change today
+10.62%
Previous close
$3.20
52-week range
$2.56 – $14.06
Valuation & dividend
Market cap
$8M
Ownership & volume
Shares outstanding
2.6M
SEC · as of 2025-12-31 · 218d STALE ↗
Insider ownership
<1%
20-F · 2026-03-26 ↗
Institutional own.
6.20%
Total held
7.1%
Tradeable float
2.4M
93% of shares · after <1% insiders + 6% institutions
Short interest
110K
▼ -66% vs prior · as of 2026-07-15
Short % of float
4.5%
Days to cover
1.0d
Avg daily volume
772K
Classification
Exchange
XASE
Relative volumevs this time of day
5mthin
0.1x
15mthin
0.1x
1hthin
0.3x
1D
1.5x

Get free CANF + market alerts in your inbox

The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.

No spam. Unsubscribe anytime. Not investment advice.

Why is $CANF up today?

7 alerts today4.9x RVOL

CANF is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 7 unusual-volume and momentum alerts on CANF today, peaking at 4.9x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.

Likely catalystForeign issuer report (6-K), from the latest SEC filing. Read it →
Why is $CANF moving? →▶ Replay the moveAuto-generated from live scanner data. Not investment advice.
Trading profile⚡ Ultra-low float · 2.4M shNot shortableNo SSRBorrow via Alpaca · SSR from Reg SHO 201
Wall Street consensusStrong Buy2 analysts
Avg target $7.50(+112% upside)
Range $7 – $8
2 buy0 hold0 sell

Analyst data via Nasdaq. Not investment advice.

Dilution watch

Active shelf

Recent share offering + active shelf on file — the company raised capital and can raise more. If $CANF runs, these filings show who may be positioned to sell new or newly-registered shares into the move.

Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.

$CANF Sentiment

Bullish
Bearish86Bullish
📰 News: 3 bull · 1 bearToday: +10.6%👥 Community: 0 bull · 0 bear

Blend of news sentiment, today’s move, and community votes. Not investment advice.

$CANF Activity

News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.

Alert· 2h ago
The Watcher SOLD $CANF at $3.3500 __THOTH_JSON__{"side":"sell","strategyLabel":"The Watcher · scalp","reason":"level_fail","shares":5,"instance":"Rider"}
at $3.35
Alert· 3h ago
The Watcher BOUGHT $CANF at $3.4400 __THOTH_JSON__{"side":"buy","strategyLabel":"The Watcher · scalp","reason":"scalp entry · coil-under9","shares":5,"instance":"Rider","setup":"coil-under9"}
at $3.44
Alert· 4h ago
The Watcher SOLD $CANF at $3.4100 __THOTH_JSON__{"side":"sell","strategyLabel":"The Watcher · scalp","reason":"stop_hit","shares":4,"instance":"Rider"}
at $3.41
Alert· 4h ago +4.3% vs EMA
CANF 200EMA (1m) Trending · 50 bars · L3 · +4.28% above EMA · slope +0.72%
at $3.50
Alert· 4h ago
The Watcher BOUGHT $CANF at $3.4300 __THOTH_JSON__{"side":"buy","strategyLabel":"The Watcher · scalp","reason":"scalp entry · coil-under9","shares":4,"instance":"Rider","setup":"coil-under9"}
at $3.43
Alert· 7h ago
The Watcher SOLD $CANF at $3.4400 __THOTH_JSON__{"side":"sell","strategyLabel":"The Watcher · scalp","reason":"stop_hit","shares":3,"instance":"Rider"}
at $3.44
Alert· 7h ago
The Watcher BOUGHT $CANF at $3.6467 __THOTH_JSON__{"side":"buy","strategyLabel":"The Watcher · scalp","reason":"scalp entry · topplay-first(1m)","shares":3,"instance":"Rider","setup":"topplay-first(1m)"}
at $3.65
Alert· 7h ago 4.9× RVOL
CANF hit 4.920x RVOL at 5:08 AM ET
at $3.55
News· SEC EDGAR· 3d ago
Can-Fite BioPharma Ltd. filed a Foreign issuer report (6-K)
Alert· 17d ago
Can-Fite Positive Phase 2a Pancreatic Cancer Study Data Accepted for Presentation at ESMO Congress 2026, One of the World's Premier Scientific Meetings in Oncology
at $3.55
Alert· 17d ago -6.20%
$CANF moved -6.20% (~15m high-low range 6.20%) (Level 5) at 7:24 AM ET
at $3.50
News· SEC EDGAR· 17d ago
Can-Fite BioPharma Ltd. filed a Foreign issuer report (6-K)
News· GlobeNewswire Inc.· 17d ago Bullish
Can-Fite Positive Phase 2a Pancreatic Cancer Study Data Accepted for Presentation at ESMO Congress 2026, One of the World's Premier Scientific Meetings in Oncology
News· SEC EDGAR· 23d ago
Can-Fite BioPharma Ltd. filed a Foreign issuer report (6-K)
News· SEC EDGAR· 31d ago
Can-Fite BioPharma Ltd. filed a Foreign issuer report (6-K)
News· GlobeNewswire Inc.· 113d ago Bullish
The Psoriasis Clinical Trial Pipeline Boom as 90+ Companies are in the Race for Better Treatments | DelveInsight
News· GlobeNewswire Inc.· 155d ago Bullish
Can-Fite’s Namodenoson Successfully Meets Primary Endpoint in Phase 2a Pancreatic Cancer Study
News· GlobeNewswire Inc.· 225d ago Bearish
Can-Fite Announces Reverse Split of its Ordinary Shares and ADS Ratio Change

Also moving today

The tickers our scanner is lighting up most over the last 48 hours.

$BJDX$CELZ$ZETA$AMIX$APPS$FLNC$AXTX$SNDK$RITR$AXTI$SSPC$SPCH

CANF stock FAQ

Why is $CANF up today?

CANF is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 7 unusual-volume and momentum alerts on CANF today, peaking at 4.9x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.

What is the CANF stock price today?

CANF last traded at $3.54, up 10.62% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).

Where can I see live CANF alerts?

The CANF Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CANF 8 times in the last 30 days.

What exchange is CANF on?

CANF (Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Ordinary Shares) trades on XASE, with a market cap of about $8M.

Is CANF good for day trading?

That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CANF for yourself. This is not investment advice.

Live data from TheDesperateTrader scanner. Not investment advice.